Oncology

Category
Oncology, the branch of medicine dedicated to the diagnosis, treatment, and research of cancer, leverages advancements in biotech, medtech, and pharma to improve patient outcomes. Biotech companies develop innovative therapies, such as immunotherapies and targeted treatments, while medtech firms create cutting-edge diagnostic tools and medical imaging technologies for early cancer detection and monitoring. Pharma companies focus on formulating and distributing effective chemotherapeutic agents and supportive care drugs. Given the high costs associated with cancer treatments, cost-effectiveness analysis and health economics are essential to demonstrate the value of new therapies. These analyses support payer negotiation, ensuring that innovative treatments are accessible and reimbursable, ultimately driving the adoption of advanced oncology solutions.

The latest developments in our clinical cost-effectiveness analyses pipeline

Clinical cost-effectiveness analyses pipeline Medip Analytics - Clinical cost-effectiveness analyses pipeline 2024

Our applications for prostate and bladder cancer are now live and actively deployed, and we are currently developing applications for melanoma and lung cancer. Additionally, breast cancer is on our development roadmap of 2024. If you would like to learn more about our developments or have inquiries about a specific disease area not included on the roadmap, please feel free to contact us or directly schedule a meeting us.

Medip Analytics develops a comprehensive suite of advanced high-tech applications designed to estimate and demonstrate the value for money of medical interventions, from diagnostics to therapeutics. These applications can be utilized throughout the entire product life cycle: from estimating potential value during product discovery, to optimizing value during development, and conveying value during sales.

Designed to help you maximize the value of your diagnostic, prognostic, or companion diagnostic product.
Medip Analytics offers a cost-effectiveness evaluation service for your diagnostic, prognostic, or companion diagnostic product across any disease area.
Our consultancy services are designed to assist companies with all health economic questions. We leverage our scientific expertise and extensive experience to advise you on your health economic strategy.

Ready to Unlock you product's potential?

Schedule a demo to see how Health Economic Software can improve the market uptake of your products.

Medip Logo
MEDIP ANALYTICS

Health Economic Software

Contact
Medip Analytics BV
Noviotech Campus Building A
Transistorweg 7
6534 AT Nijmegen
The Netherlands
+31 24 700 9837
© 2024 Medip Analytics B.V. All Rights Reserved.